Experimental insights reveal targeted protein degradation in BRD4 using new glutarimides, highlighting translational potential.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Neigenfind et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: